Senior Director, Field Reimbursement

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most. The Senior Director, Field Reimbursement will build and lead Capricor's U.S. field reimbursement team in support of the anticipated launch of deramiocel, Capricor's lead cell therapy for Duchenne muscular dystrophy. The role is responsible for designing the field reimbursement model, hiring and leading the Patient Engagement & Reimbursement Liaison team, and making sure prescribers, treatment centers, and families get timely, compliant support from benefits investigation through prior authorization, appeals, and treatment. This leader partners closely with Trade & Patient Services, Payer Strategy & Engagement, the hub vendor, National Account Directors, Sales, Infusion Site Nurse Educators, Medical Affairs, Legal, and Compliance.